AACR logo

More articles from Poster Presentations - Targets and Therapies in Pediatric Cancer

Abstract 2889: The Yes-Associated Protein plays a role in tumor formation, stemness, and therapy response in high risk neuroblastoma
Jenny Shim, Yoo Joo Lee, Kaitlyn Janssen, Alexa Fritz, Kelly C. Goldsmith

Cancer Research Jul 2019, 79 (13 Supplement) 2889; DOI: 10.1158/1538-7445.AM2019-2889
Abstract 2879: TYRO3 is a potential therapeutic target in pediatric acute myeloid leukemia
Sherri K. Smart, Manali Rupji, Bhakti Dwivedi, Jeanne Kowalski, Deborah DeRyckere, Douglas K. Graham

Cancer Research Jul 2019, 79 (13 Supplement) 2879; DOI: 10.1158/1538-7445.AM2019-2879
Abstract 2874: De novo acquisition of RD3 loss with intensive multi-modal therapy harmonize neuroblastoma relapse
Dinesh Babu Somasundaram, Karthikeyan Subramanian, Sheeja Aravindan, Zhongxin Yu, Mohan Natarajan, Terence S. Herman, Natarajan Aravindan

Cancer Research Jul 2019, 79 (13 Supplement) 2874; DOI: 10.1158/1538-7445.AM2019-2874
Abstract 2867: MDM2 and MDM4 are therapeutic vulnerabilities in malignant rhabdoid tumors
Thomas P. Howard, Taylor E. Arnoff, Melinda R. Song, Andrew O. Giacomelli, Xiaofeng Wang, Andrew L. Hong, Neekesh V. Dharia, Su Wang, Francisca Vazquez, Minh-Tam Pham, Ann M. Morgan, Franziska Wachter, Gregory H. Bird, Guillaume Kugener, Elaine M. Oberlick, Matthew G. Rees, Hong Tiv, Justin H. Hwang, Katherine H. Walsh, April Cook, John M. Krill-Burger, Aviad Tsherniak, Prafulla C. Gokhale, Peter J. Park, Kimberly Stegmaier, Loren D. Walensky, William C. Hahn, Charles W. Roberts

Cancer Research Jul 2019, 79 (13 Supplement) 2867; DOI: 10.1158/1538-7445.AM2019-2867
Abstract 2885: Angiotensin-(1-7) prevents doxorubicin-induced cardiotoxicity by reducing oxidative stress and fibrosis
Patricia E. Gallagher, Omeed Rahimi, Brian Westwood, Jay Kirby, Jasmina Varagic, Elisabeth Ann Tallant

Cancer Research Jul 2019, 79 (13 Supplement) 2885; DOI: 10.1158/1538-7445.AM2019-2885
Abstract 2875: Targeted therapy of Ewing’s sarcoma by human anti CD99 targeted hybrid polymerized liposomal nanoparticles (HPLNs) encapsulating anticancer agents
HyungGyoo Kang, Jon Nagy, Sheetal Mitra, Triche Triche

Cancer Research Jul 2019, 79 (13 Supplement) 2875; DOI: 10.1158/1538-7445.AM2019-2875
Abstract 2865: AsiDNA^TM, a novel DNA repair inhibitor to sensitize aggressive medulloblastoma subtypes
Sofia Ferreira, Chloe Foray, Sophie Heinrich, Celio Pouponnot, Marie Dutreix

Cancer Research Jul 2019, 79 (13 Supplement) 2865; DOI: 10.1158/1538-7445.AM2019-2865
Abstract 2866: Surfaceome profiling in osteosarcoma: Identification of the candidate immunotherapeutic target
Yifei Wang, Zhongting Zhang, Sankaranarayanan Kannan, Wendong Zhang, Michael Roth, Jonathan B. Gill, Zhaohui Xu, Xiangjun Tian, Jing Wang, Richard Gorlick

Cancer Research Jul 2019, 79 (13 Supplement) 2866; DOI: 10.1158/1538-7445.AM2019-2866
Abstract 2887: Patient-derived 3-dimensional models of pediatric tumors for in situ study of cancer biology, immunotherapy, and drug treatment
Padraic P. Levings, Juan M. Urueña, Eric O. McGhee, Alex J. McGhee, Derek L. Hood, Kylie E. Van Meter, Steve H. Ghivizzani, Colin J. Anderson, Wallace G. Sawyer

Cancer Research Jul 2019, 79 (13 Supplement) 2887; DOI: 10.1158/1538-7445.AM2019-2887
Abstract 2883: Mithramycin inhibits KDM6A (UTX) and SWI/SNF to induce apoptosis in malignant rhabdoid tumor
Maggie H. Chasse, Elissa Boguslawski, Katie Sorensen, Ian Beddows, Kristin Rybski, Zachary Madaj, Susan M. Kitchen-Goosen, Patrick J. Grohar

Cancer Research Jul 2019, 79 (13 Supplement) 2883; DOI: 10.1158/1538-7445.AM2019-2883

Main menu

User menu

Search

More articles from Poster Presentations - Targets and Therapies in Pediatric Cancer

Pages

Articles

Info for

About Cancer Research